Published in Eur J Cancer Prev on February 01, 2005
Epidemiology and management of liver metastases from colorectal cancer. Ann Surg (2006) 3.37
Patterns of colorectal cancer care in Europe, Australia, and New Zealand. J Natl Cancer Inst Monogr (2013) 0.93
Quality indicators for colorectal cancer surgery and care according to patient-, tumor-, and hospital-related factors. BMC Cancer (2012) 0.91
A Suitable Approach to Estimate Cancer Incidence in Area without Cancer Registry. J Cancer Epidemiol (2011) 0.86
Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat Med (1999) 8.01
EUROCARE-3: survival of cancer patients diagnosed 1990-94--results and commentary. Ann Oncol (2003) 5.78
Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J Immunol (2000) 5.37
TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature (2001) 5.24
Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization. Nat Immunol (2000) 5.01
Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells. Eur J Immunol (2001) 4.23
Understanding variations in survival for colorectal cancer in Europe: a EUROCARE high resolution study. Gut (2000) 4.02
Tolerization of dendritic cells by T(S) cells: the crucial role of inhibitory receptors ILT3 and ILT4. Nat Immunol (2002) 3.91
BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon alpha/beta induction. J Exp Med (2001) 3.40
Calcium and fibre supplementation in prevention of colorectal adenoma recurrence: a randomised intervention trial. European Cancer Prevention Organisation Study Group. Lancet (2000) 3.26
A DAP12-mediated pathway regulates expression of CC chemokine receptor 7 and maturation of human dendritic cells. J Exp Med (2001) 3.18
Mitochondrial DNA deletion in Pearson's marrow/pancreas syndrome. Lancet (1989) 2.98
Automatic record hash coding and linkage for epidemiological follow-up data confidentiality. Methods Inf Med (1998) 2.80
Survival of colorectal cancer patients in Europe during the period 1978-1989. EUROCARE Working Group. Eur J Cancer (1998) 2.74
NK3-specific natural killer cells are selectively inhibited by Bw4-positive HLA alleles with isoleucine 80. J Exp Med (1994) 2.61
Cancer incidence and mortality in France over the period 1978-2000. Rev Epidemiol Sante Publique (2003) 2.25
A novel inhibitory receptor (ILT3) expressed on monocytes, macrophages, and dendritic cells involved in antigen processing. J Exp Med (1997) 2.05
Lymph node harvest reporting in patients with carcinoma of the large bowel: a French population-based study. Cancer (1998) 1.96
Cloning of novel immunoglobulin superfamily receptors expressed on human myeloid and lymphoid cells: structural evidence for new stimulatory and inhibitory pathways. Eur J Immunol (1997) 1.95
Cancer incidence and mortality in France over the period 1980-2005. Rev Epidemiol Sante Publique (2008) 1.88
The French National Mesothelioma Surveillance Program. Occup Environ Med (2006) 1.87
Sequential involvement of Lck and SHP-1 with MHC-recognizing receptors on NK cells inhibits FcR-initiated tyrosine kinase activation. Immunity (1996) 1.87
Colorectal adenocarcinoma in patients under 45 years of age: comparison with older patients in a well-defined French population. Dis Colon Rectum (2001) 1.87
A population-based study of the incidence, management and prognosis of hepatic metastases from colorectal cancer. Br J Surg (2006) 1.81
A time trend analysis of papillary and follicular cancers as a function of tumour size: a study of data from six cancer registries in France (1983-2000). Eur J Cancer (2007) 1.81
Presentation of viral antigen by MHC class I molecules is dependent on a putative peptide transporter heterodimer. Nature (1992) 1.79
Tetrameric complexes of human histocompatibility leukocyte antigen (HLA)-G bind to peripheral blood myelomonocytic cells. J Exp Med (1999) 1.77
Cancer survival increases in Europe, but international differences remain wide. Eur J Cancer (2001) 1.76
Organization of the leukocyte receptor cluster (LRC) on human chromosome 19q13.4. Mamm Genome (1999) 1.71
A human killer inhibitory receptor specific for HLA-A1,2. J Immunol (1996) 1.70
[Results and participation factors to the European Randomized study of Screening for Prostate Cancer (ERSPC) with Prostate Specific Antigen: French departments of Tarn and Hérault]. Prog Urol (2009) 1.67
Ductal carcinoma in situ of the male breast. Analysis of 31 cases. Eur J Cancer (1997) 1.67
Tobacco, alcohol, and colorectal tumors: a multistep process. Am J Epidemiol (1995) 1.65
The ILT2(LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules co-expressed on target cells. Eur J Immunol (1999) 1.64
Colonoscopic screening in first-degree relatives of patients with 'sporadic' colorectal cancer: a case-control study. The Association Nationale des Gastroentérologues des Hôpitaux and Registre Bourguignon des Cancers Digestifs (INSERM CRI 9505) Gastroenterology (1998) 1.62
Activating interactions in human NK cell recognition: the role of 2B4-CD48. Eur J Immunol (1999) 1.62
Multi-state Markov models in cancer screening evaluation: a brief review and case study. Stat Methods Med Res (2010) 1.60
Incidence and patterns of recurrence after resection for cure of colonic cancer in a well defined population. Br J Surg (2006) 1.59
How to ensure data security of an epidemiological follow-up: quality assessment of an anonymous record linkage procedure. Int J Med Inform (1998) 1.58
The CD94/NKG2-A inhibitory receptor complex is involved in natural killer cell-mediated recognition of cells expressing HLA-G1. J Immunol (1997) 1.58
Trends in the management and survival of digestive tract cancers among patients aged over 80 years. Aliment Pharmacol Ther (2005) 1.58
Comparative value of tumour grade, hormonal receptors, Ki-67, HER-2 and topoisomerase II alpha status as predictive markers in breast cancer patients treated with neoadjuvant anthracycline-based chemotherapy. Eur J Cancer (2004) 1.57
Prospective multicenter study of vascular-catheter-related complications and risk factors for positive central-catheter cultures in intensive care unit patients. J Clin Microbiol (1990) 1.56
Disability, psychosocial factors and mortality among the elderly in a rural French population. J Clin Epidemiol (1990) 1.55
Susceptibility or resistance to lysis by alloreactive natural killer cells is governed by a gene in the human major histocompatibility complex between BF and HLA-B. Proc Natl Acad Sci U S A (1990) 1.54
Estimating sensitivity and sojourn time in screening for colorectal cancer: a comparison of statistical approaches. Am J Epidemiol (1998) 1.54
Breast cancer in patients treated for Hodgkin's disease: clinical and pathological analysis of 76 cases in 63 patients. Eur J Cancer (1997) 1.53
Asthma among workers in healthcare settings: role of disinfection with quaternary ammonium compounds. Clin Exp Allergy (2014) 1.52
Activation of NK cell-mediated cytotoxicity by a SAP-independent receptor of the CD2 family. J Immunol (2001) 1.51
Comparison of interval breast cancer rates for two-versus single-view screening mammography: a population-based study. Breast (2009) 1.49
Male breast cancer: results of the treatments and prognostic factors in 397 cases. Eur J Cancer (1995) 1.48
Benefit of operative mortality reduction on colorectal cancer survival. Br J Surg (2002) 1.48
European guidelines for quality assurance in colorectal cancer screening and diagnosis: overview and introduction to the full supplement publication. Endoscopy (2012) 1.44
Ig-like transcript 2 (ILT2)/leukocyte Ig-like receptor 1 (LIR1) inhibits TCR signaling and actin cytoskeleton reorganization. J Immunol (2001) 1.42
Patients with X-linked lymphoproliferative disease have a defect in 2B4 receptor-mediated NK cell cytotoxicity. Eur J Immunol (2000) 1.42
Primary lung adenocarcinoma: characteristics by smoking habit and sex. Eur Respir J (2011) 1.42
Tyrosine phosphorylation of a human killer inhibitory receptor recruits protein tyrosine phosphatase 1C. J Exp Med (1996) 1.42
Clinical, molecular, and genotype-phenotype correlation studies from 25 cases of oral-facial-digital syndrome type 1: a French and Belgian collaborative study. J Med Genet (2006) 1.42
Cutting edge: signal-regulatory protein beta 1 is a DAP12-associated activating receptor expressed in myeloid cells. J Immunol (2000) 1.41
[Appendectomy, cholecystectomy, cholelithiasis and colorectal cancer. A retrospective case control study at the Côte-d'Or]. Gastroenterol Clin Biol (1991) 1.40
[How to choose in practice a model to describe the geographic variation of cancer incidence? Example of gastrointestinal cancers from Côte-d'Or]. Rev Epidemiol Sante Publique (2002) 1.39
Incidence and management of malignant digestive endocrine tumours in a well defined French population. Gut (2004) 1.39
The role of general practitioners in diagnosis of cutaneous melanoma: a population-based study in France. Br J Dermatol (2012) 1.39
Incidence of thyroid cancer in adults recorded by French cancer registries (1978-1997). Eur J Cancer (2002) 1.39
Colorectal adenoma characteristics as predictors of recurrence. Dis Colon Rectum (2004) 1.38
Measuring cancer prevalence in Europe: the EUROPREVAL project. Ann Oncol (2002) 1.38
Energy intake, body mass index, physical activity, and the colorectal adenoma-carcinoma sequence. Nutr Cancer (2001) 1.38
[A diagnostic strategy for isolated pulmonary nodules less than 2 cm in diameter]. Rev Mal Respir (2002) 1.37
Modelling the effect of breast cancer screening on related mortality using French data. Cancer Epidemiol (2010) 1.37
[Disposable versus reusable biopsy forceps. A prospective cost analysis in the gastrointestinal endoscopy unit of the Dijon University Hospital]. Gastroenterol Clin Biol (2001) 1.37
Prospective study of prognostic factors in patients with unresected hepatic metastases from colorectal cancer. Fondation Française de Cancérologie Digestive. Br J Surg (1995) 1.34
Variation over time of the effects of prognostic factors in a population-based study of colon cancer: comparison of statistical models. Am J Epidemiol (1999) 1.34
Colon cancer in France: evidence for improvement in management and survival. Gut (2002) 1.34
Survival of cancer patients in France: a population-based study from The Association of the French Cancer Registries (FRANCIM). Eur J Cancer (2006) 1.33